Imagine discovering that a drug you’ve probably never thought twice about—one that costs less than a pack of gum—could help combat one of the most serious cancers today. That’s the buzz in the medical world after researchers uncovered surprising new evidence about metformin, a cheap and widely prescribed medication for type 2 diabetes. It might just be doing double duty: managing blood sugar and fighting colon cancer.
A Budget-Friendly Drug with Big Potential
Metformin has long been a go-to treatment for diabetes. It works by improving the body’s response to insulin and helping lower glucose production in the liver. Its safety record is solid, having been used for over 60 years, and it’s so inexpensive that a single pill can cost as little as 20 cents. But now, scientists are beginning to think that this humble drug could quietly be holding anti-cancer secrets.
Researchers at The Ohio State University recently presented a study at a prestigious cancer research conference in Chicago, revealing that metformin might slow down the growth of colon cancer cells. This is especially exciting news in cases where cancer is driven by KRAS gene mutations—genetic alterations that often make the disease more aggressive and notoriously difficult to treat.
What Makes KRAS Mutations So Tough?
To fully appreciate metformin’s new role, it helps to understand what makes KRAS mutations such a big deal. KRAS is a gene that acts like an “on” switch for cell growth. When mutated, it can become stuck in the “on” position, causing cells to divide uncontrollably—one of the hallmarks of cancer.
Unfortunately, KRAS mutations are common in colon, lung, and pancreatic cancers, and traditional treatments often struggle to make a dent. These mutations are also known for resisting many of the newest targeted cancer therapies, leaving doctors with fewer options.
So when something as widely available as metformin starts showing potential against KRAS-driven cancers, the medical community pays close attention.
Read more: Doctor Beats Cancer Using Treatment He Helped Invent—He’s Now Been Cancer-Free For Over A Year
How Does Metformin Affect Cancer Cells?
In lab tests, researchers observed that metformin seems to throw a wrench into the way cancer cells generate energy. Typically, cancer cells consume glucose at a furious rate to fuel their rapid growth. This is sometimes called the “Warburg effect,” a type of metabolic hijacking that helps tumors thrive.
Metformin disrupts this energy-grabbing system. It tampers with a part of the cell’s energy-making machinery called the mitochondria and activates a key enzyme known as AMPK. Think of AMPK as a cellular energy regulator that tells the cell, “We’re low on fuel—slow everything down.”
By activating AMPK, metformin effectively reduces the ability of cancer cells to continue multiplying at high speed. It doesn’t kill them outright like chemotherapy, but it may weaken them enough that traditional treatments work better—or prevent them from spreading as fast in the first place.
Why This Matters: A New Weapon in the Cancer Arsenal
Cancer treatment is rarely about just one solution. Oncologists often combine surgery, radiation, and chemotherapy in complex ways depending on the patient. But those options can come with high costs, intense side effects, and mixed results—especially in advanced stages of cancer.
The idea of adding a low-cost, low-risk pill like metformin to that mix is deeply appealing. If further research confirms its benefits, metformin could potentially become a standard “add-on” treatment—especially for people with certain genetic profiles, like KRAS mutations.
Plus, since metformin is already FDA-approved for diabetes, its path to becoming a cancer treatment might be shorter than for entirely new drugs. Repurposing existing medications is a growing trend in medicine—it’s faster, cheaper, and safer than starting from scratch.
Read more: Scientists Develop New Urine Test Can Detect Pancreatic and Prostate Cancer Early—with High Accuracy
From Petri Dish to Patients: The Road Ahead
The current findings are based on laboratory research, which means scientists have observed metformin’s effects on cancer cells in controlled settings. The next step is to test the drug in animals, which will help determine how it performs in living systems with immune responses and complex organ interactions.
If those results are promising, human clinical trials will follow. These trials would explore key questions like: What dosage works best? Are there any new side effects when used for cancer? Does it work better for some patients than others?
This process could take several years, but given metformin’s long history of safe use, researchers are optimistic that progress will be swift.
Could This Be a Glimpse Into the Future of Cancer Treatment?
This isn’t the first time metformin has been linked to potential anti-cancer benefits. In fact, over the past decade, several observational studies have noticed that people with diabetes who take metformin tend to have lower rates of certain cancers, including colon, liver, and breast cancer. But correlation isn’t causation, and until now, the mechanisms weren’t fully understood.
This latest study helps connect the dots, giving scientists a clearer picture of how metformin might be working against cancer at the cellular level. If these findings continue to hold up in larger studies, this everyday drug might soon take on an extraordinary new role.
And for patients and families facing the overwhelming challenges of cancer treatment, even the possibility of an affordable, low-risk supplement to existing therapies could be a huge relief.
Aspirin’s Surprising Side Hustle: Cancer Fighter?
Aspirin—yes, the same tiny pill tucked away in most medicine cabinets, often used to ease headaches or thin the blood—might just have a secret identity. Beyond its role in managing pain and preventing heart attacks, scientists have been quietly exploring its potential to protect against cancer, particularly in the colon. And the findings so far? Let’s just say this over-the-counter classic might be doing more good than we ever gave it credit for.
🧪 More Than a Pain Reliever
At the heart of aspirin’s unexpected cancer-fighting potential is its anti-inflammatory power. Inflammation, though part of the body’s natural defense system, can also become a breeding ground for disease if it lingers too long. Chronic inflammation has been linked to a number of health issues, including the kind of cellular damage that can eventually lead to cancer.
Aspirin works by inhibiting enzymes known as COX-1 and COX-2 (short for cyclooxygenase). These enzymes are key players in the body’s inflammation pathways. COX-2, in particular, has drawn attention in cancer research because it’s often found at elevated levels in cancerous tissue—especially in the colon. By blocking these enzymes, aspirin not only dulls pain but also potentially disrupts conditions that allow abnormal cells to form and flourish.
Read more: Scientists Say Cancer Can Now Be Detected Years in Advance with Simple Blood Test
📊 The Evidence So Far
Numerous observational studies and clinical trials over the past two decades have linked regular low-dose aspirin use to a modest but meaningful reduction in the risk of developing colorectal cancer. For example, long-term use—typically defined as daily use for at least 5 to 10 years—has been associated with up to a 20–30% reduction in colorectal cancer incidence and death.
One of the most notable studies, published in The Lancet in 2010, followed thousands of individuals over a 20-year span and found that daily aspirin use significantly lowered the risk of colon cancer, especially in people over 50. More recently, a large review conducted by the U.S. Preventive Services Task Force (USPSTF) concluded that certain adults at higher risk for cardiovascular disease might benefit from aspirin therapy not only for heart protection, but also as a bonus: reduced colorectal cancer risk.
🚨 But It’s Not a Cure-All
Now, before you start popping aspirin like breath mints, let’s be clear: this isn’t a miracle pill, and it’s definitely not without its risks. Aspirin can cause gastrointestinal bleeding, stomach ulcers, and in rare cases, hemorrhagic stroke. These side effects are more likely to occur in older adults, those with certain health conditions, or individuals taking other medications that thin the blood.
Because of this, medical experts stress that aspirin should not be taken daily for cancer prevention unless recommended by a doctor who has evaluated your specific risk factors. Like most things in medicine, context matters. What might be helpful for one person could be harmful to another.
